Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury

Kidney International

Volumn 62, Issue 4, 2002, Pages 1249-1263

  Chatterjee, Prabal K ^a,b,c,d,e   Zacharowski, Kai ^a,b,c,d,e   Cuzzocrea, Salvatore ^a,b,c,d,e   Brown, Paul A J ^a,b,c,d,e   Stewart, Keith N ^a,b,c,d,e   Mota Filipe, Helder ^a,b,c,d,e   Thiemermann, Christoph ^a,b,c,d,e  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF LISBON   (Portugal)

Author keywords

Gram positive bacteria; Inducible nitric oxide synthase; Kidney transplantation; Lipopolysaccharide; Nitric oxide; P selectin; Peroxynitrite; Reperfusion injury

Indexed keywords

3 NITROTYROSINE; BACTERIUM LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MALONALDEHYDE; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PADGEM PROTEIN; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0036380998     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2002.kid580.x     Document Type: Article

References (74)

1. STAR RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
2. LAMEIRE N, VANHOLDER R: Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol 12:S20-S32, 2001
3. PALLER MS: The cell biology of reperfusion injury in the kidney. J Invest Med 42:632-639, 1994
4. MCCOMS PR, ROBERTS B: Acute renal failure following resection of abdominal aortic aneurysm. Surg Gynecol Obstet 148:175-178, 1979
5. ARONSON S, BLUMENTHAL R: Perioperative renal dysfunction and cardiovascular anesthesia: Concerns and controversies. J Cardiothorac Vasc Anesth 17:117-130, 1998
6. BOOM H, MALLAT MJ, DE FIJTER JW, et al: Delayed graft function influences renal function, but not survival. Kidney Int 58:859-866, 2000
7. BONVENTRE JV: Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11:43-48, 2002
8. OGAWA T, MIMURA Y, HIKI N, et al: Ischaemic preconditioning ameliorates functional disturbance and impaired renal perfusion in rat ischaemia-reperfused kidneys. Clin Exp Pharmacol Physiol 27:997-1001, 2000
9. RIERA M, HERRERO I, TORRAS J, et al: Ischemic preconditioning improves postischemic acute renal failure. Transplant Proc 31:2346-2347, 1999
10. TOOSY N, MCMORRIS ELJ, GRACE PA, MATHIE RT: Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int 84:489-494, 1999
11. COCHRANE J, WILLIAMS BT, BANERJEE A, et al: Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Renal Fail 21:135-145, 1999
12. CHIEN CT, CHEN CF, HSU SM, et al: Protective mechanism of preconditioning hypoxia attenuates apoptosis formation during renal ischemia/reperfusion phase. Transplant Proc 31:2012-2013, 1999
13. 2+-mediated cell toxicity in renal tubular epithelial cells (BSC-1). Cell Stress Chap 2:175-179, 1997
14. PARK KW, CHEN A, BONVENTRE JV: Prevention of kidney ischemia/reperfusion-induced functional injury, JNK, p38, and MAP kinase kinase activation by remote ischemic pretreatment. J Biol Chem 276:11870-11876, 2001
15. TAKAOKA A, NAKAE I, MITSUNAMI K, et al: Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: Effects of "remote" preconditioning. J Am Coll Cardiol 33:556-564, 1999
16. 3 receptors. Am J Physiol 278:F380-F387, 2000
17. YANG CW, AHN HJ, HAN HJ, et al: Pharmacological preconditioning with low-dose cyclosporin or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation 72:1753-1759, 2001
18. YANG CW, KIM BS, KIM J, et al: Preconditioning with sodium arsenite inhibits apoptotic cell death in the rat kidney with ischemia/reperfusion or cyclosporine-induced injuries. The possible role of heat-shock protein 70 as a mediator of ischemic tolerance. Exp Nephrol 9:284-294, 2001
19. HEEMAN U, SZABO A, HAMAR P, et al: Lipopolysacchride pretreatment protects from renal ischemia/reperfusion injury. Am J Pathol 156:287-293, 2000
20. THIEMERMANN C: Nitric oxide and septic shock. Gen Pharmacol 29:159-166, 1997
21. JOHNSON JP, ROKAW MD: Sepsis or ischemia in experimental acute renal failure: What have we learned? New Horiz 3:608-614, 1995
22. YAO Z, AUCHAMPACH JA, PIEPER GM, GROSS GJ: Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res 27:832-838, 1993
23. ASTIZ ME, RACKOW EC, STILL JG, et al: Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: A prospective, double-blind, randomised, controlled trial. Crit Care Med 23:9-17, 1995
24. MADONNA GS, PETERSON JE, RIBI EE, VOGEL SN: Early-phase endotoxin tolerance: Induction by a detoxified lipid A derivative, monophosphoryl lipid A. Infect Immun 52:6-11, 1986
25. ELLIOTT GT, SOWELL CG, WALKER EB, et al: The novel glycolipd RC-552 attenuates myocardial stunning and reduces infarct size in dogs. J Mol Cell Cardiol 32:1327-1339, 2000
26. REDDY TS, KISHORE V: Distribution and localisation of monophosphoryl lipid A in selected tissues of the rat. Immunopharmacol Immunotoxicol 18:145-159, 1996
27. FISCHER W: Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol 29:233-302, 1988
28. BONE RC: Gram-positive organisms and sepsis. Arch Intern Med 154:26-34, 1994
29. KENGATHARAN M, DE KIMPE SJ, THIEMERMANN C: Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br J Pharmacol 117:1163-1170, 1996
30. AUGUET M, LONCHAMPT MO, DELAFLOTTE J, et al: Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS Lett 297:183-185, 1992
31. HATTORI Y, KASAI K, NAKANISHI N, et al: Induction of nitric oxide and tetrahydrobiopterin synthesis by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. J Vasc Res 35:104-108, 1998
32. LIN C-H, KUAN I-H, LEE H-M, et al: Induction of cyclooxygenase-2 protein by lipoteichoic acid from Staphylococcus aureus in human pulmonary epithelial cells: Involvement of a nuclear factor-κB-dependent pathway. Br J Pharmacol 134:543-552, 2001
33. DE KIMPE SJ, HUNTER ML, BRYANT CE, et al: Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetised rats. Br J Pharmacol 114:1317-1323, 1995
34. MERINO G, FUJINO Y, HANASHIRO RK: Lipoteichoic acid as an inducer of acute uveitis in the rat. Invest Ophthalmol Vis Sci 39:1251-1256, 1998
35. BUCHER M, ITTNER KP, ZIMMERMANN M, et al: NO synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Lett 412:511-514, 1997
36. HYZY J, SCIOTTI V, ALBINI B, STINSON M: Deposition of circulating streptococcal lipoteichoic acid in mouse tissues. Microb Pathog 13:123-132, 1992
37. ZACHAROWSKI K, FRANK S, OTTO M, et al: Lipoteichoic acid and endotoxin induce a second window of protection in the rat heart. Arterioscler Thromb Vasc Biol 20:1521-1528, 2000
38. ZACHAROWSKI K, CHATTERJEE PK, THIEMERMANN C: Delayed preconditioning induced by lipoteichoic acid from B. subtillis and S. aureus is not blocked by administration of 5-hydroxydecanoate. Shock 17:19-22, 2002
39. ZACHAROWSKI K, OTTO M, HAFNER G, et al: Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology. Arterioscler Thromb Vasc Biol 19:2276-2280, 1999
40. BROWN JM, GROSSO MA, TERADA LS, et al: Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 86:2516-2520, 1989
41. CHATTERJEE PK, CUZZOCREA S, BROWN PAJ, et al: Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58:658-673, 2000
42. CHATTERJEE PK, ZACHAROWSKI K, CUZZOCREA S, et al: Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetised rat in vivo. FASEB J 14:641-651, 2000
43. MCWHINNIE DL, THOMPSON JF, TAYLOR HM, et al: Morphometric analysis of cellular infiltration assessed by monoclonal antibody labeling in sequential human renal allograft biopsies. Transplantation 42:352-358, 1986
44. COCKERILL GW, MCDONALD MC, MOTA-FILIPE H, et al: High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock. FASEB J 15:1941-1952, 2001
45. CHATTERJEE PK, BROWN PAJ, CUZZOCREA S, et al: Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int 59:2073-2083, 2001
46. CHATTERJEE PK, PATEL NSA, KVALE EO, et al: Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61:862-871, 2002
47. ZARANADO G, MICHIELON P, PACCAGNELLA A, et al: Acute renal failure in the patient undergoing cardiac operation. J Thorac Cardiovasc Surg 107:1489-1495, 1994
48. MAHER ER, ROBINSON KN, SCOBLE JE, et al: Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 72:857-866, 1989
49. MCCARTHY JT: Prognosis of patients with acute renal failure in the intensive care unit: A tale of two eras. Mayo Clin Proc 71:117-126, 1996
50. FELLSTROM B: Nonimmune risk factors for chronic renal allograft dysfunction. Transplantation 71:SS10-SS16, 2001
51. MOLITORIS BA, MARRS J: The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106:583-592, 1999
52. RABB H, O'MEARA YM, MADERNA P, et al: Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 51:1463-1468, 1997
53. CHAMOUN F, BURNE M, O'DONNELL M, et al: Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. Frontiers Biosci 5:e103-e109, 2000
54. LAURIAT S, LINAS SL: The role of neutrophils in acute renal failure. Semin Nephrol 18:498-504, 1998
55. HEIZELMANN M, MERCER-JONES MA, PASSMORE JC: Neutrophils and renal failure. Am J Kidney Dis 34:384-399, 1999
56. EISERICH JP, HRISTOVA M, CROSS CE, et al: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397, 1998
57. PALLER MS: Pathophysiologic mechanisms of acute renal failure, in Mechanisms of Injury in Renal Disease and Toxicity, edited by GOLDSTEIN RS, Ann Arbor, CRC Press, 1994, pp 3-13
58. BREZIS FH, EPSTEIN MD: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 332:647-655, 1995
59. WILLINGER CC, SCHRAMEK H, PFALLER K, PFALLER W: Tissue distribution of neutrophils in postischemic acute renal failure. Virchows Arch B Cell Pathol 62:237-243, 1992
60. LIEBERTHAL W: Biology of ischemic and toxic renal tubular cell injury: Role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 7:289-295, 1998
61. 3 segments. Kidney Int 14:31-49, 1978
62. WEIGHT SC, NICHOLSON ML: Nitric oxide and renal reperfusion injury: A review. Eur J Vasc Endovasc Surg 16:98-103, 1998
63. NOIRI E, PERESIENI T, MILLER F, et al: In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 97:2377-2383, 1996
64. LING H, EDELSTEIN C, GENGARO P, et al: Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 277:F383-F390, 1999
65. RADI R, PELUFFO G, ALVAREZ MN, et al: Unraveling peroxynitrite formation in biological systems. Free Rad Biol Med 30:463-488, 2001
66. BECKMAN JS: Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9:836-844, 1996
67. BECKMAN JS, BECKMAN TW, CHEN J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990
68. 6-(1-Iminoethyl)-lysine. J Pharmacol Exp Ther 295:417-422, 2000
69. NOIRI E, NAKAO A, UCHIDA K, et al: Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol 281:F948-F957, 2001
70. JEFAYRI MK, GRACE PA, MATHIE RT: Attenuation of reperfusion injury by renal ischemic preconditioning: Role of nitric oxide. BJU Int 85:1007-1013, 2000
71. NANDAGOPAL K, DAWSON TM, DAWSON VL: Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 297:474-478, 2001
72. BOLLI R: Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J Mol Cell Cardiol 33:1897-1918, 2001
73. OGAWA T, NUSSLER AK, TUZUNER E, et al: Contribution of nitric oxide to the protective effects of ischemic preconditioning in ischemia-reperfused rat kidneys. J Lab Clin Med 138:50-58, 2001
74. LINAS S, WHITTENBURG D, REPINE JE: Nitric oxide prevents neutrophil-mediated acute renal failure. Am J Physiol 272:F48-F54, 1997